Vanta Bioscience Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 - - -
Growth matrix (%)        
Revenue growth -- -- -- --
Op profit growth -- -- -- --
EBIT growth -- -- -- --
Net profit growth -- -- -- --
Profitability ratios (%)        
OPM 30.90 -- -- --
EBIT margin 23.30 -- -- --
Net profit margin 7.22 -- -- --
RoCE -- -- -- --
RoNW -- -- -- --
RoA -- -- -- --
Per share ratios ()        
EPS 1.60 -- -- --
Dividend per share -- -- -- --
Cash EPS (0.30) -- -- --
Book value per share 37.20 -- -- --
Valuation ratios        
P/E 56.90 -- -- --
P/CEPS (343) -- -- --
P/B 2.45 -- -- --
EV/EBIDTA 16.70 -- -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (25) -- -- --
Liquidity ratios        
Debtor days -- -- -- --
Inventory days -- -- -- --
Creditor days -- -- -- --
Leverage ratios        
Interest coverage (1.70) -- -- --
Net debt / equity 0.73 -- -- --
Net debt / op. profit 3.93 -- -- --
Cost breakup ()        
Material costs (8.30) -- -- --
Employee costs (36) -- -- --
Other costs (25) -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 - - -
Revenue 14.10 -- -- --
yoy growth (%) -- -- -- --
Raw materials (1.20) -- -- --
As % of sales 8.34 -- -- --
Employee costs (5.10) -- -- --
As % of sales 35.90 -- -- --
Other costs (3.50) -- -- --
As % of sales 24.90 -- -- --
Operating profit 4.37 -- -- --
OPM 30.90 -- -- --
Depreciation (1.20) -- -- --
Interest expense (1.90) -- -- --
Other income 0.11 -- -- --
Profit before tax 1.34 -- -- --
Taxes (0.30) -- -- --
Tax rate (25) -- -- --
Minorities and other 0.01 -- -- --
Adj. profit 1.02 -- -- --
Exceptional items -- -- -- --
Net profit 1.02 -- -- --
yoy growth (%) -- -- -- --
NPM 7.22 -- -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 - - -
Profit before tax 1.34 -- -- --
Depreciation (1.20) -- -- --
Tax paid (0.30) -- -- --
Working capital -- -- -- --
Other operating items -- -- -- --
Operating cashflow -- -- -- --
Capital expenditure -- -- -- --
Free cash flow -- -- -- --
Equity raised -- -- -- --
Investments -- -- -- --
Debt financing/disposal -- -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash -- -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 - -
Equity capital 6.31 6.31 -- --
Preference capital -- -- -- --
Reserves 17.20 15.90 -- --
Net worth 23.50 22.30 -- --
Minority interest
Debt 17.40 13.30 -- --
Deferred tax liabilities (net) 0.59 0.40 -- --
Total liabilities 42.40 36.90 -- --
Fixed assets 27.80 21.60 -- --
Intangible assets
Investments -- 1.95 -- --
Deferred tax asset (net) -- -- -- --
Net working capital 14.50 10.10 -- --
Inventories 14 9.24 -- --
Inventory Days 362 -- -- --
Sundry debtors 1.39 1.56 -- --
Debtor days 35.90 -- -- --
Other current assets 5.22 1.38 -- --
Sundry creditors (3.20) (0.50) -- --
Creditor days 81.60 -- -- --
Other current liabilities (3) (1.60) -- --
Cash 0.20 3.27 -- --
Total assets 42.40 36.90 -- --
Switch to
Consolidated
Standalone


Report not showing data